Interferon-β inhibits activated leukocyte migration through human brain microvascular endothelial cell monolayer

Laboratory Investigation

Volumn 79, Issue 8, 1999, Pages 1015-1025

  Lou, Jinning ^a,b,f   Gasche, Yvan ^a   Zheng, Lei ^a   Giroud, Christine ^a   Morel, Philippe ^b   Clements, John ^c   Ythier, Arnaud ^d   Grau, Georges E ^a,e  

^a University Medical Center   (Switzerland)

^b UNIVERSITY HOSPITAL   (Switzerland)

^c British Biotechnology   (United Kingdom)

^d Serono International SA   (Switzerland)

^e AIX MARSEILLE UNIVERSITY   (France)

^f UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; BRAIN MICROCIRCULATION; CELL MIGRATION; CENTRAL NERVOUS SYSTEM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LEUKOCYTE MIGRATION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MICROVASCULATURE; MOLECULAR INTERACTION; OLIGODENDROGLIA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION;

BRAIN; CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; COLLAGENASES; ENDOTHELIUM, VASCULAR; HUMANS; INTEGRIN ALPHA4BETA1; INTEGRINS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; INTERFERON-BETA; INTERLEUKIN-1; LEUKOCYTES; MATRIX METALLOPROTEINASE 9; MICROCIRCULATION; MULTIPLE SCLEROSIS; RECEPTORS, LYMPHOCYTE HOMING; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0032788593     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Abdulahad A, Shah S, and Galazka A (1997). Treatment of multiple sclerosis with Interferon beta-1. Neurology 49:641.
2. Archelos JJ, Jung S, Maurer M, Schmied M, Lassmann H, Tamatani T, Miyasaka M, Toyka KV, and Hartung HP (1993). Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1. Ann Neurol 34:145-154.
3. Arnason BGW (1993). Interferon-beta in multiple sclerosis. Neurology 43:641-643.
4. Arnason BGW, Dayal A, Qu ZX, Jensen MA, Gene K, and Reder AT (1996). Mechanisms of action of interferon-beta in multiple sclerosis. Springer Semin Immunopathol 18:125-148.
5. Berman ME, Xie Y, and Muller WA (1996). Roles of platelet endothelial cell adhesion molecule-1 (PECAM-1, CD31) in natural killer cell transendothelial migration and beta(2) integrin activation. J Immunol 156:1515-1524.
6. Biegel D, Spencer DD, and Pachter JS (1995). Isolation and culture of human brain microvessel endothelial cells for the study of blood-brain barrier properties in vitro. Brain Res 692:183-189.
7. Brosnan CF, Cannella B, Battistini L, and Raine CS (1995). Cytokine localization in multiple sclerosis lesions: Correlation with adhesion molecule expression and reactive nitrogen species. Neurology 45:S16-S21.
8. Calabresi PA, Pelfrey CM, Tranquill LR, Maloni H, and McFarland HF (1997). VLA-4 expression on peripheral blood lymphocytes is downregulated after treatment of multiple sclerosis with interferon beta. Neurology 49:1111-1116.
9. Cannella B, Cross AH, and Raine CS (1991). Adhesion-related molecules in the central nervous system: Upregulation correlates with inflammatory cell influx during relapsing experimental autoimmune encephalomyelitis. Lab Invest 65: 23-31.
10. Clements JM, Cossins JA, Wells GMA, Corkill DJ, Helfrich K, Wood LM, Pigott R, Stabler G, Ward GA, Gearing AJH, and Miller KM (1997). Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumor necrosis factor-alpha inhibitor. J Neuroimmunol 74:85-94.
11. Coclet-Ninin J, Dayer JM, and Burger D (1997). Interferon-beta not only inhibits interleukin-1 and tumor necrosis factor-alpha but stimulates interleukin-1 receptor antagonist production in human peripheral blood mononuclear cells. Eur Cytokine Netw 8:345-349.
12. Cornelius LA, Nehring LC, Roby JD, Parks WC, and Welgus HG (1995). Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration. J Invest Dermatol 105:170-176.
13. Doyle C and Stromiger JL (1987). Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature 330:256-259.
14. Elices MJ, Osborn L, Takada Y, Crouse C, Luhowskyj S, Hemler ME, and Lobb RR (1990). VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4 fibronectin binding site. Cell 60:577-584.
15. Entman ML, Youker K, Shoji T, Kukielka G, Shappell SB, Taylor AA, and Smith CW (1992). Neutrophil induced oxidative injury of cardiac myocytes: A compartmented system requiring CD11b/CD18-ICAM-1 adherence. J Clin Invest 90: 1335-1345.
16. Gearing AJH, Beckett P, Christodoulou M, Churchill M, Clements JM, Crimmin M, Davidson AH, Drummond AH, Galloway WA, Gilbert R, Gordon JL, Leber TM, Mangan M, Miller K, Nayee P, Owen K, Patel S, Thomas W, Wells G, Wood LM, and Woolley K (1995). Matrix metalloproteinases and processing of pro-TNF-alpha. J Leukoc Biol 57:774-777.
17. +) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy. J Clin Invest 99:2664-2671.
18. Gijbels K, Galardy RE, and Steinman L (1994). Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J Clin Invest 94:2177-2182.
19. Goetzl EJ, Banda MJ, and Leppert D (1996). Matrix metalloproteinases in immunity. J Immunol 156:1-4.
20. Hall GL, Compston A, and Scolding NJ (1997). Beta-interferon and multiple sclerosis. Trends Neurosci 20:63-67.
21. Hauser SL, Doolittle TH, Lincoln R, Brown RH, and Dinarello CA (1990). Cytokine accumulations in CSF of multiple sclerosis patients: Frequent detection of interleukin-1 and tumor necrosis factor but not interieukin-6. Neurology 40:1735-1739.
22. Hofman FM, Hinton DR, Johnson K, and Merrill JE (1989). Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 170:607-612.
23. Hogg N and Landis RC (1993). Adhesion molecules in cell interactions. Curr Opin Immunol 5:383-390.
24. Hohlfeld R, Londei M, Massacesi L, and Salvetti M (1995). T-cell auto-immunity in multiple sclerosis. Immunol Today 16:259-261.
25. Horikoshi T, Ezoe K, Nakagawa H, Eguchi H, Hanada N, and Hamaoka S (1995). Upregulation of ICAM-1 expression on human dermal fibroblasts by IFN-beta in the presence of TNF-alpha. FEBS Lett 363:141-144.
26. Jiang H, Williams GJ, and Dhibjalbut S (1997). The effect of interferon beta-1b on cytokine-induced adhesion molecule expression. Neurochem Int 30:449-453.
27. Kavanaugh AF, Lightfoot E, Lipsky PE, and Oppenheimermarks N (1991). Role of CD11/CD18 in adhesion and transendothelial migration of T-cells: Analysis utilizing CD18-deficient T-cell clones. J Immunol 146:4149-4156.
28. Kent SJ, Karlik SJ, Cannon C, Mines DK, Yednock TA, Fritz LC, and Horner HC (1995). A monoclonal antibody to alpha 4 integrin suppresses and reverses active experimental allergic encephalomyelitis. J Neuroimmunol 58;1-10.
29. Kirby JA, Leon MP, Douglas MS, and Rix DA (1997). Development of a flow-cytometric assay to identify and quantify lymphocytes that bind to endothelial and epithelial cells. Biochem Soc Trans 25:736-740.
30. Kleiner DE and Stetler-Stevenson WG (1994). Quantitative zymography: Detection of picogram quantities of gelatinases. Anal Biochem 218:325-329.
31. Liao F, Huynh HK, Eiroa A, GreeneT, Polizzi E, and Muller WA (1995). Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1. J Exp Med 182:1337-1343.
32. Lou J, Bühler L, Deng S, Mentha G, Montesano R, Grau GE, and Morel P (1998). Inhibition of leukocyte adherence and transendothelial migration in cultured human liver vascular endothelial cells by prostaglandin E1. Hepatology 27:822-828.
33. Lou J, Chofflon M, Juillard C, Donati Y, Mill N, Siegrist CA, and Grau GE (1997). Brain microvascular endothelial cells and leukocytes derived from patients with multiple sclerosis exhibit increased adhesion capacity. Neuroreport 8:629-633.
34. Lou J, Dayer JM, Grau GE, and Burger D (1996). Direct cell/cell contact with stimulated T lymphocytes induces the expression of cell adhesion molecules and cytokines by human brain microvascular endothelial cells. Eur J Immunol 26:3107-3113.
35. Maeda A and Sobel RA (1996). Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. J Neuropathol. Exp Neurol 55:300-309.
36. Maimone D, Gregory S, Arnason BGW, and Reder T (1991). Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. J Neuroimmunol 32:67-74.
37. Masuyama JI, Minato N, and Kano S (1986). Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture: T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon. J Clin Invest 77:1596-1605.
38. Miller A, Lanir N, Shapiro S, Revel M, Honigman S, Kinarty A, and Lahat N (1996). Immunoregulatory effects of interferon-beta and interacting cytokines on human vascular endothelial cells implications for multiple sclerosis and other autoimmune diseases. J Neuroimmunol 64:151-161.
39. Noronha A, Toscas A, and Jensen MA (1990). Interferon-beta augments suppressor cell function in multiple sclerosis. Ann Neurol 27:207-210.
40. Noronha A, Toscas A, and Jensen MA (1993). Interferon-beta decreases T-cell activation and interferon-gamma production in multiple sclerosis. J Neuroimmunol 46:145-154.
41. Oppenheimermarks N, Davis LS, and Lipsky PE (1990). Human lymphocyte-T adhesion to endothelial cells and transendothelial migration: Alteration of receptor use relates to the activation status of both the T-cell and the endothelial cell. J Immunol 145:140-148.
42. Osborn L (1990). Leukocyte adhesion to endothelium in inflammation. Cell 62:3-6.
43. Peter JB, Boctor FN, and Tourtellotte WW (1991). Serum and CSF Levels of IL-2, sIL-2R, TNF-alpha, and IL-1 beta in chronic progressive multiple sclerosis: Expected lack of clinical utility. Neurology 41:121-123.
44. Pober JS and Cotran RS (1991). Immunologic interactions of lymphocytes-T with vascular endothelium. Adv Immunol 50: 261-302.
45. Rival Y, Del Maschio A, Rabiet MJ, Dejana E, and Duperray A (1996). Inhibition of platelet endothelial cell adhesion molecule-1 synthesis and leukocyte transmigration in endothelial cells by the combined action of TNF-alpha and IFN-gamma. J Immunol 157:1233-1241.
46. Romer LH, Mclean NV, Van HC, Daise M, Sun J, and Delisser HM (1995). IFN-gamma and TNF-alpha induce redistribution-of PECAM-1 (CD31) on human endothelial cells. J Immunol 154:6582-6592.
47. Rosenberg GA (1995). Matrix metalloproteinases in brain injury. J Neurotrauma 12:833-842.
48. Shi FL and Audus KL (1994). Biochemical characteristics of primary and passaged cultures of primate brain microvessel endothelial cells. Neurochem Res 19:427-433.
49. Shimizu Y, Newman W, Gopal TV, Horgan KJ, Graber N, Beall LD, Vanseventer GA, and Shaw S (1991). Four molecular pathways of T-cell adhesion to endothelial cells: Roles of LFA-1, VCAM-1, and ELAM-1 and changes in pathway hierarchy under different activation conditions. J Cell Biol 113:1203-1212.
50. Smith CW, Marlin SD, Rothlein R, Toman C, and Anderson DC (1989). Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J Clin Invest 83:2008-2017.
51. Springer TA (1990). Adhesion receptors of the immune system. Nature 346:425-434.
52. Stewart RJ, Kashour TS, and Marsden PA (1996). Vascular endothelial platelet endothelial cell adhesion molecule-1 (PECAM-1) expression is decreased by TNF-alpha and IFN-gamma: Evidence for cytokine-induced destabilization of messenger ribonucleic acid transcripts in bovine endothelial cells. J Immunol 156:1221-1228.
53. Stoolman LM (1989). Adhesion molecules controlling lymphocyte migration. Cell 56:907-910.
54. Stuve O, Dooley NP, Uhm JH, Antel JP, Francis GS, Williams G, and Yong VW (1996). Interferon beta-1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase-9. Ann Neurol 40:853-863.
55. Svenningsson A, Dotevall L, Stemme S, and Andersen O (1997). Increased expression of B7-1 costimulatory molecule on cerebrospinal fluid cells of patients with multiple sclerosis and infectious central nervous system disease. J Neuroimmunol 75:59-68.
56. Svenningsson A, Hansson GK, Andersen O, Andersson R, Patarroyo M, and Stemme S (1993). Adhesion molecule expression on cerebrospinal fluid T-lymphocytes: Evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls. Ann Neurol 34:155-161.
57. Takahashi M, Ikeda U, Masuyama JI, Kitagawa SI, Kasahara T, Saito M, Kano S, and Shimada K (1994). Involvement of adhesion molecules in human monocyte adhesion to and transmigration through endothelial cells in vitro. Atherosclerosis 108:73-81.
58. Tsukada N, Miyagi K, Matsuda M, Yanagisawa N, and Yone K (1991). Tumor necrosis factor and interleukin-1 in the CSF and sera of patients with multiple sclerosis. J Neurol Sci 104:230-234.
59. Vankooyk Y, Vandewielvankemenade E, Weder P, Huijbens RJF, and Figdor CG (1993). Lymphocyte function-associated antigen-1 dominates very late antigen-4 in binding of activated T-cells to endothelium. J Exp Med 177:185-190.
60. Washington R, Burton J, Todd RF, Newman W, Dragovic L, and Doreduffy P (1994). Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis. Ann Neurol 35:89-97.
61. Welsh CT, Rose JW, Hill KE, and Townsend JJ (1993). Augmentation of adoptively transferred experimental allergic encephalomyelitis by administration of a monoclonal antibody specific for LFA-1-alpha. J Neuroimmunol 43:161-167.
62. Yednock TA, Cannon C, Fritz LC, Sanchez Madrid F, Steinman L, and Karin N (1992). Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha4beta1 integrin. Nature 356:63-66.
63. Yu M, Nishiama A, Trapp BD, and Tuohy VK (1996). Interferon-beta inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis. J Neuroimmunol 64:91-100.